Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13G/A for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN).
- Disclosed ownership: 4.2%.
- Date of event: 31 Dec 2025.
ORBIMED ADVISORS LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED CAPITAL LLC
- Symbol
- VTGN
- Shares outstanding
- 39,040,476 shares
- Disclosed Ownership
- 1,639,700 shares
- Ownership
- 4.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 18:33:07 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 4.2% ownership in Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 18:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 3.6% | 1,420,300 | 0 | 1,420,300 | /s/ Carl L. Gordon | Carl L. Gordon/Member | |
| ORBIMED CAPITAL LLC | 4.2% | 1,639,700 | 1,639,700 | 0 | /s/ Carl L. Gordon | Carl L. Gordon/Member |